Hsbc Holdings PLC Buys New Shares in Viemed Healthcare, Inc. (NASDAQ:VMD)

Hsbc Holdings PLC purchased a new position in Viemed Healthcare, Inc. (NASDAQ:VMD) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,425 shares of the company’s stock, valued at approximately $108,000.

Several other institutional investors have also recently made changes to their positions in VMD. LPL Financial LLC increased its holdings in shares of Viemed Healthcare by 1.6% in the fourth quarter. LPL Financial LLC now owns 194,690 shares of the company’s stock worth $1,561,000 after purchasing an additional 3,000 shares during the last quarter. Martingale Asset Management L P grew its holdings in Viemed Healthcare by 11.0% during the 4th quarter. Martingale Asset Management L P now owns 34,836 shares of the company’s stock valued at $279,000 after buying an additional 3,451 shares in the last quarter. Bard Associates Inc. increased its stake in Viemed Healthcare by 1.3% in the 4th quarter. Bard Associates Inc. now owns 349,526 shares of the company’s stock worth $2,803,000 after acquiring an additional 4,474 shares during the last quarter. R Squared Ltd bought a new stake in Viemed Healthcare in the 4th quarter worth approximately $41,000. Finally, Barclays PLC raised its holdings in shares of Viemed Healthcare by 9.7% during the 4th quarter. Barclays PLC now owns 58,635 shares of the company’s stock worth $470,000 after acquiring an additional 5,196 shares in the last quarter. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Stock Down 1.6%

NASDAQ VMD opened at $6.32 on Monday. The stock has a 50 day moving average price of $7.07 and a 200-day moving average price of $7.91. Viemed Healthcare, Inc. has a one year low of $6.14 and a one year high of $9.81. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The company has a market capitalization of $249.79 million, a P/E ratio of 23.41 and a beta of 1.49.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The business had revenue of $59.10 million during the quarter, compared to analyst estimates of $60.60 million.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.